Effect of vitamin D3 on behavioural and biochemical parameters in diabetes type 1-induced rats

Cell Biochemistry and Function

Volumn 32, Issue 6, 2014, Pages 502-510

  Calgaroto, Nicéia Spanholi ^a   Thomé, Gustavo Roberto ^a   da Costa, Pauline ^a   Baldissareli, Jucimara ^a   Hussein, Fátima Abdala ^a   Schmatz, Roberta ^a   Rubin, Maribel A ^a   Signor, Cristiane ^a   Ribeiro, Daniela Aymone ^a   Carvalho, Fabiano Barbosa ^a   de Oliveira, Lizielle Souza ^a   Pereira, Luciane Belmonte ^a   Morsch, Vera Maria ^a   Schetinger, Maria Rosa Chitolina ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Cholecalciferol; Cholinesterase; Diabetes; Memory

Indexed keywords

ACETYLCHOLINESTERASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); COLECALCIFEROL; GLUCOSE; METFORMIN; PORPHOBILINOGEN SYNTHASE; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; VITAMIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BIOCHEMISTRY; BODY WEIGHT; BRAIN CORTEX; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETOGENESIS; DRUG EFFECT; ENZYME ACTIVITY; EXPERIMENTAL DISEASE; FLUID INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEMORY; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; TREATMENT DURATION; ANIMAL; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; EATING; FEAR; METABOLISM; PSYCHOLOGY; WISTAR RAT;

ANIMALIA; RATTUS;

ACETYLCHOLINESTERASE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CEREBRAL CORTEX; CHOLECALCIFEROL; DIABETES MELLITUS, TYPE 1; EATING; FEAR; HYPOGLYCEMIC AGENTS; MALE; MEMORY; METFORMIN; PORPHOBILINOGEN SYNTHASE; RATS, WISTAR; SODIUM-POTASSIUM-EXCHANGING ATPASE; STREPTOZOCIN; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMINS;

EID: 84905906769     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.3044     Document Type: Article

References (53)

1. Biessels GJ, Deary IJ, Ryan CM. Cognition and diabetes: a lifespan perspective. Lancet Neurol 2008; 7: 184-190.
2. Davis EA, Soong SA, Byrne GC, Jones TW. Acute hyperglycaemia impairs cognitive function in children with IDDM. J Pediatr Endocrinol Metab 1996; 9: 455-461.
3. Perantie DC, Lim A, Wu J, et al. Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus. Pediatr Diabetes 2008; 9: 87-95.
4. Desrocher M, Rovet J. Neurocognitive correlates of type 1 diabetes mellitus in childhood. Child Neuropsychol 2004; 10: 36-52.
5. Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev 2008; 29: 494-511.
6. Rother KI. Diabetes treatment-bridging the divide. N Engl J Med 2007; 356: 1499-1501.
7. Meerza D, Naseem I, Ahmed J. Can Vitamin D be a potential treatment for type 2 diabetes mellitus. Diabetes Metab Syndr Clin Res Rev 2010; 4: 245-248.
8. George N, Kumar TP, Antony S, Jayanarayanan S, Paulose CS. Effect of vitamin D3 in reducing metabolic and oxidative stress in the liver of streptozotocin-induced diabetic rats. Br J Nutr 2012; 108: 1410-1418.
9. Peeyush KT, Savitha B, Sherin A, Anju TR, Jes P, Paulose CS. Cholinergic, dopaminergic and insulin receptors gene expression in the cerebellum of streptozotocin-induced diabetic rats: functional regulation with Vitamin D3 supplementation. Pharmacol Biochem Behav 2010; 95: 216-222.
10. Eyles D, Almeras L, Benech P, et al. Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. J Steroid Biochem Mol Biol 2007; 103: 538-545.
11. Sonnenberg J, Luine VN, Krey LC, Christakos S. 1, 25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei. Endocrinology 1986; 118: 1433-1439.
12. Humble MB. Vitamin D. Light and mental health. J Photochem Photobiol B 2010; 101: 142-149.
13. Kumar PT, Antony S, Nandhu MS, Sadanandan J, Naijil G, Paulose CS. Vitamin D3 restores altered cholinergic and insulin receptor expression in the cerebral cortex and muscarinic M3 receptor expression in pancreatic islets of streptozotocin induced diabetic rats. J Nutr Biochem 2011; 22: 418-425.
14. Borges AC, Feres T, Vianna LM, Paiva TB. Cholecalciferol treatment restores the relaxant responses of spontaneously hypertensive rat arteries to bradykinin. Pathophysiology 2002; 8: 263-268.
15. Rubin MA, Berlese DB, Stiegemeier JA, et al. Intra-amygdala administration of polyamines modulates fear conditioning in rats. J Neurosci 2004; 24: 2328-2334.
16. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
17. Sassa S. Delta-aminolevulinic acid dehydratase assay. Enzyme 1982; 28: 133-145.
18. Wyse AT, Streck EL, Barros SV, Brusque AM, Zugno AI, Wajner M. Methylmalonate administration decreases Na+, K+-ATPase activity in cerebral cortex of rats. Neuroreport 2000; 11: 2331-2334.
19. Carvalho FB, Mello CF, Marisco PC, et al. Spermidine decreases Na(+), K(+)-ATPase activity through NMDA receptor and protein kinase G activation in the hippocampus of rats. Eur J Pharmacol 2012; 684: 79-86.
20. Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem 1925; 66: 375-400.
21. Ellman GL, Courtney KD, Andres V, Jr, Feather-Stone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961; 7: 88-95.
22. Rocha JB, Heinzmann Bulow NM, Correa EF, Scholze C, Nogueira CW, Barbosa NB. Dexmedetomidine protects blood delta-aminolevulinate dehydratase from inactivation caused by hyperoxygenation in total intravenous anesthesia. Hum Exp Toxicol 2010; 30: 289-295.
23. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
24. Schmatz R, Mazzanti CM, Spanevello R, et al. Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats. Eur J Pharmacol 2009; 610: 42-48.
25. Vinagre A, Rönnau AS, Pereira S, Silveira L, Wiilland EF, Suyenaga ES. Anti-diabetic effects of Campomanesia xanthocarpa (Berg) leaf decoction. Braz J Pharm Sci 2010; 46: 169-177.
26. Ashokkumar N, Pari L. Effect of N-benzoyl-D-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic rats. Clin Chim Acta 2005; 351: 105-113.
27. Dimo T, Rakotonirina SV, Tan PV, et al. Effect of Sclerocarya birrea (Anacardiaceae) stem bark methylene chloride/methanol extract on streptozotocin-diabetic rats. J Ethnopharmacol 2007; 110: 434-438.
28. Vasconcelos CF, Maranhao HM, Batista TM, et al. Hypoglycaemic activity and molecular mechanisms of Caesalpinia ferrea Martius bark extract on streptozotocin-induced diabetes in Wistar rats. J Ethnopharmacol 2011; 137: 1533-1541.
29. Zeitz U, Weber K, Soegiarto DW, Wolf E, Balling R, Erben RG. Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor. FASEB J 2003; 17: 509-511.
30. Del Pino-Montes J, Benito GE, Fernandez-Salazar MP, et al. Calcitriol improves streptozotocin-induced diabetes and recovers bone mineral density in diabetic rats. Calcif Tissue Int 2004; 75: 526-532.
31. Biessels GJ. Diabetes: hypoglycemia and dementia in type 2 diabetes: chick or egg? Nat Rev Endocrinol 2009; 5: 532-534.
32. Simpson IA, Appel NM, Hokari M, et al. Blood-brain barrier glucose transporter: effects of hypo- and hyperglycemia revisited. J Neurochem 1999; 72: 238-247.
33. Folmer V, Soares JC, Gabriel D, Rocha JB. A high fat diet inhibits delta-aminolevulinate dehydratase and increases lipid peroxidation in mice (Mus musculus). J Nutr 2003; 133: 2165-2170.
34. Lepoivre M, Flaman JM, Bobe P, Lemaire G, Henry Y. Quenching of the tyrosyl free radical of ribonucleotide reductase by nitric oxide. Relationship to cytostasis induced in tumor cells by cytotoxic macrophages. J Biol Chem 1994; 269: 21891-21897.
35. Alhaider AA, Korashy HM, Sayed-Ahmed MM, Mobark M, Kfoury H, Mansour MA. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression. Chem Biol Interact 2011; 192: 233-242.
36. Bhutada P, Mundhada Y, Bansod K, et al. Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes. Behav Brain Res 2011; 220: 30-41.
37. Fu J, Yuan J, Zhang N, et al. Anti-diabetic activities of Acanthopanax senticosus polysaccharide (ASP) in combination with metformin. Int J Biol Macromol 2012; 50: 619-623.
38. Wiseman H. Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. FEBS Lett 1993; 326: 285-288.
39. Vague P, Coste TC, Jannot MF, Raccah D, Tsimaratos M. C-peptide, Na+, K(+)-ATPase, and diabetes. Exp Diabesity Res 2004; 5: 37-50.
40. Christian B, McConnaughey K, Bethea E, et al. Chronic aspartame affects T-maze performance, brain cholinergic receptors and Na+, K+-ATPase in rats. Pharmacol Biochem Behav 2004; 78: 121-127.
41. Zhang LN, Sun YJ, Pan S, et al. Na(+)-K(+)-ATPase, a potent neuroprotective modulator against Alzheimer disease. Fundam Clin Pharmacol 2012; 27: 96-103.
42. Benarroch EE. Na+, K+-ATPase: functions in the nervous system and involvement in neurologic disease. Neurology 2011; 76: 287-293.
43. Rivelli JF, Amaiden MR, Monesterolo NE, et al. High glucose levels induce inhibition of Na, K-ATPase via stimulation of aldose reductase, formation of microtubules and formation of an acetylated tubulin/Na, K-ATPase complex. Int J Biochem Cell Biol 2012; 44: 1203-1213.
44. Chung SS, Ho EC, Lam KS, Chung SK. Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 2003; 14: S233-236.
45. Morre DM, Lenaz G, Morre DJ. Surface oxidase and oxidative stress propagation in aging. J Exp Biol 2000; 203: 1513-1521.
46. Chung SS, Chung SK. Genetic analysis of aldose reductase in diabetic complications. Curr Med Chem 2003; 10: 1375-1387.
47. Baynes JW, Thorpe SR. Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 1999; 48: 1-9.
48. Kade IJ, Nogueira CW, Rocha JB. Diphenyl diselenide and streptozotocin did not alter cerebral glutamatergic and cholinergic systems but modulate antioxidant status and sodium pump in diabetic rats. Brain Res 2009; 1284: 202-211.
49. Stahl SM. Blue genes and the monoamine hypothesis of depression. J Clin Psychiatry 2000; 61: 77-78.
50. Szutowicz A, Tomaszewicz M, Bielarczyk H. Disturbances of acetyl-CoA, energy and acetylcholine metabolism in some encephalopathies. Acta Neurobiol Exp (Wars) 1996; 56: 323-339.
51. Biessels GJ, Braun KP, de Graaf RA, van Eijsden P, Gispen WH, Nicolay K. Cerebral metabolism in streptozotocin-diabetic rats: an in vivo magnetic resonance spectroscopy study. Diabetologia 2001; 44: 346-353.
52. Van Beek AH, Claassen JA. The cerebrovascular role of the cholinergic neural system in Alzheimer's disease. Behav Brain Res 2010; 221: 537-542.
53. Fan Y, Hu J, Li J, et al. Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci Lett 2005; 374: 222-226.